C1C2C3C5 Part IV Pharmacies

Annotations:
Modifications etc. (not altering text)
C1

Pt. IV: Power to amend conferred (N.I.) (2.4.2001) by 2001 c. 3 (N.I.), s. 60, Sch. 4 para. 2(2); S.R. 2001/128, art. 2(4), Sch.

C2

Pt. IV amendment to earlier affecting provision SI 1994/3144 reg. 9 (30.10.2005) by Medicines (Marketing Authorisations Etc.) Amendment Regulations 2005 (S.I. 2005/2759), regs. 1(a), 2(12)

C3

Pt. IV modified (E.W.S.) (coming into force in accordance with art. 1(2)(3)) by Pharmacists and Pharmacy Technicians Order 2007 (S.I. 2007/289), art. 1(2)(3), Sch. 2 para. 13(7)

C5

Pt. IV (except ss. 80-83): Power to amend conferred (15.3.2000) by 1999 c. 8, ss. 60(1)(2)(4), 67(1), Sch. 3 para. 2(3)(b); S.I. 2000/779, art. 2

Persons lawfully conducting retail pharmacy business

72 Representative of pharmacist in case of death or disability.

1

The provisions of this section shall have effect where a pharmacist carries on a retail pharmacy business and—

a

he dies, or

b

he is adjudged bankrupt or enters into a composition or scheme or deed of arrangement with his creditors, or, in Scotland, sequestration of his estate is awarded or he makes a trust deed for behoof of his creditors or a composition contract, or

c

F8he becomes a person who lacks capacity (within the meaning of the Mental Capacity Act 2005) to carry on the business, or, in Scotland, a F1guardian or judicial factor is appointed for him on the ground that he suffers from mental disorder, or, in Northern Ireland, F14a controller is appointed in his case under the Mental Health (Northern Ireland) Order 1986,

and a representative of his thereafter carries on his business.

F71A

In subsection (1)(c), the reference to a person who lacks capacity to carry on the business is to a person—

a

in respect of whom there is a donee of an enduring power of attorney or lasting power of attorney (within the meaning of the Mental Capacity Act 2005), or

b

for whom a deputy is appointed by the Court of Protection,

and in relation to whom the donee or deputy has power for the purposes of this Act.

F122

The conditions referred to in section 69(1)(c) of this Act are—

a

that the name and address of the representative, and the name of the pharmacist whose representative he is, have been notified to the registrar, and

b

that subsections (2A) and (2B) of this section are both satisfied as respects each of the premises at F16or from which the business is carried on and medicinal products, other than medicinal products on a general sale list, are sold by retail.

2A

This subsection is satisfied if a responsible pharmacist is in charge of F17the business carried on at or from the premises mentioned in subsection (2)(b) of this section, so far as concerns—

a

the retail sale at F18or from those premises of medicinal products (whether they are on a general sale list or not), and

b

the supply at F19or from those premises of such products in circumstances corresponding to retail sale.

2B

This subsection is satisfied if a notice is conspicuously displayed at those premises stating—

a

the name of the responsible pharmacist for the time being,

b

F13the number of his registration under Part 4 of the Pharmacy Order 2010 or, in relation to Northern Ireland, under the Pharmacy (Northern Ireland) Order 1976, and

c

the fact that he is for the time being in charge of F20the business carried on at or from those premises.

C43

The period referred to in section 69(1)(c) of this Act—

a

in the case of the death of a pharmacist, is a period of five years from the date of his death;

b

in the case of the bankruptcy or sequestration of the estate of a pharmacist, is a period of three years from the date on which he is adjudged bankrupt or the date of the award of sequestration, as the case may be;

c

in the case of a composition or scheme or deed of arrangement, or of a trust deed or composition contract, is a period of three years from the date on which the trustee appointed thereunder becomes entitled to carry on the business; and

d

in a case falling within subsection (1)(c) of this section, is a period of three years from the date of the appointment of the F9deputy, F2curator bonis, judicial factor, committee or guardian F10or from the date of registration of the instrument appointing the donee,

or, in any such case, is such longer period as, on the application of the representative, F6the relevant disciplinary committee, having regard to all the circumstances of the case, may direct.

4

In this section “representative”—

a

in relation to a pharmacist who has died, means his executor or administrator and, in respect of a period of three months from the date of his death, if he has died leaving no executor who is entitled and willing to carry on the business, includes any person beneficially interested in his estate;

b

in a case falling within paragraph (b) of subsection (1) of this section, means the trustee in bankruptcy or the trustee in the sequestration or any trustee appointed under the composition scheme, deed of arrangement, trust deed or composition contract; and

c

in a case falling within paragraph (c) of that subsection, means the F11donee, deputy, F2curator bonis, judicial factor, F15controller or guardian F3; and in paragraph (b) above the reference to a trustee appointed under a composition, scheme or deed of arrangement includes a reference to the supervisor of a F4voluntary arrangement proposed for the purposes of, and approved under, Part VIII of the Insolvency Act 1986F5or Chapter II of Part VIII of the Insolvency (Northern Ireland) Order 1989.